Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas? : A cohort study - 15/02/15
Abstract |
Background |
Although consensus guidelines for pretreatment evaluation and monitoring of propranolol therapy in patients with infantile hemangiomas (IH) have been formulated, little is known about the cardiovascular side effects.
Objectives |
We sought to analyze cardiovascular evaluations in patients with IH at baseline and during treatment with an oral beta-blocker.
Methods |
Data from 109 patients with IH were retrospectively analyzed. Patient and family history, pretreatment electrocardiogram (ECG), heart rate, and blood pressure were evaluated before initiation of beta-blocker therapy. Blood pressure and standardized questionnaires addressing side effects were evaluated during treatment.
Results |
Questionnaire analyses (n = 83) identified 3 cases with a family history of cardiovascular disease in first-degree relatives. ECG findings were normal in each case and no serious complication of therapy occurred. ECG abnormalities were found in 6.5% of patients but there were no contraindications to beta-blocker therapy and no major complications. Hypotension in 9 patients did not require therapy adjustment. In all, 88 parents (81%) reported side effects during beta-blocker treatment.
Limitations |
The relatively small patient cohort is a limitation.
Conclusion |
Pretreatment ECG is of limited value for patients with an unremarkable cardiovascular history and a normal heart rate and blood pressure. Hypotension may occur during treatment.
Le texte complet de cet article est disponible en PDF.Key words : beta-blocker therapy, cardiovascular side effects, infantile hemangioma, treatment evaluation
Abbreviations used : BP, ECG, HR, IH
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Reprints not available from the authors. |
Vol 72 - N° 3
P. 465-472 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?